ELABELA alleviates syncytiotrophoblast hypoxia/reoxygenation injury and preeclampsia-like symptoms in mice by reducing apoptosis

Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt 1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J. Clin. Invest., 111, 649, 10.1172/JCI17189

Sibai, 2005, Pre-eclampsia, Lancet (N. Am. Ed.), 365, 785, 10.1016/S0140-6736(05)17987-2

Longtine, 2012, Villous trophoblast apoptosis is elevated and restricted to cytotrophoblasts in pregnancies complicated by preeclampsia, IUGR, or preeclampsia with IUGR, Placenta, 33, 352, 10.1016/j.placenta.2012.01.017

Whitley, 2007, Increased apoptosis in first trimester extravillous trophoblasts from pregnancies at higher risk of developing preeclampsia, Am. J. Pathol., 170, 1903, 10.2353/ajpath.2007.070006

Szklanna, 2017, Comparative proteomic analysis of trophoblast cell models reveals their differential phenotypes, potential uses, and limitations, Proteomics, 17, 10.1002/pmic.201700037

Roland, 2016, Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia, Cell. Mol. Life Sci., 73, 365, 10.1007/s00018-015-2069-x

Burton, 2019, Pre-eclampsia: pathophysiology and clinical implications, BMJ, 366, l2381, 10.1136/bmj.l2381

Bainbridge, 2006, Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast, Am. J. Pathol., 169, 774, 10.2353/ajpath.2006.060184

Chng, 2013, ELABELA: a hormone essential for heart development signals via the apelin receptor, Dev. Cell, 27, 672, 10.1016/j.devcel.2013.11.002

Ho, 2015, ELABELA is an endogenous growth factor that sustains hESC self-renewal via the PI3K/AKT pathway, Cell Stem Cell, 17, 435, 10.1016/j.stem.2015.08.010

Ho, 2017, ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice, Science, 357, 707, 10.1126/science.aam6607

Wang, 2019, Reduced ELABELA expression attenuates trophoblast invasion through the PI3K/AKT/mTOR pathway in early onset preeclampsia, Placenta, 87, 38, 10.1016/j.placenta.2019.08.077

Zhou, 2019, ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ, Am. J. Physiol. Endocrinol. Metab., 316, E773, 10.1152/ajpendo.00383.2018

Georgiadou, 2019, Peptide hormone ELABELA enhances extravillous trophoblast differentiation, but placenta is not the major source of circulating ELABELA in pregnancy, Sci. Rep., 9, 19077, 10.1038/s41598-019-55650-5

Szklanna, 2017, Comparative proteomic analysis of trophoblast cell models reveals their differential phenotypes, potential uses, and limitations, Proteomics, 17, 10.1002/pmic.201700037

Orendi, 2011, Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia, Placenta, 32, S49, 10.1016/j.placenta.2010.11.023

Lanoix, 2013, Melatonin: the watchdog of villous trophoblast homeostasis against hypoxia/reoxygenation-induced oxidative stress and apoptosis, Mol. Cell. Endocrinol., 381, 35, 10.1016/j.mce.2013.07.010

Sagrillo-Fagundes, 2018, Melatonin modulates autophagy and inflammation protecting human placental trophoblast from hypoxia/reoxygenation, J. Pineal Res., 65, 10.1111/jpi.12520

Hu, 2020, Cyclophilin A inhibits trophoblast migration and invasion in vitro and vivo through p38/ERK/JNK pathways and causes features of preeclampsia in mice, Life Sci., 261, 118351, 10.1016/j.lfs.2020.118351

Rossant, 2001, Placental development: lessons from mouse mutants, Nat. Rev. Genet., 2, 538, 10.1038/35080570

Hassan, 2019, Reducing maternal mortality: can elabela help in this fight?, Lancet (N. Am. Ed.), 394, 8, 10.1016/S0140-6736(19)30543-4

Panaitescu, 2020, ELABELA plasma concentrations are increased in women with late-onset preeclampsia, J. Matern. Fetal Neonatal Med., 33, 5, 10.1080/14767058.2018.1484089

Yallampalli, 1993, Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia, Am. J. Obstet. Gynecol., 169, 1316, 10.1016/0002-9378(93)90299-X

Khalil, 1998, Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats, Hypertension, 31, 1065, 10.1161/01.HYP.31.5.1065

Osol, 2009, Inhibition of nitric oxide synthases abrogates pregnancy-induced uterine vascular expansive remodeling, J. Vasc. Res., 46, 478, 10.1159/000200963

Zuo, 2020, Melatonin attenuates hypertension and oxidative stress in a rat model of L-NAME-induced gestational hypertension, Vasc. Med., 25, 295, 10.1177/1358863X20919798

Motta, 2015, Effect of sildenafil on pre-eclampsia-like mouse model induced by L-name, Reprod. Domest. Anim., 50, 611, 10.1111/rda.12536

Souza, 2012, Hepatoprotective and anti-inflammatory effects of silibinin on experimental preeclampsia induced by L-NAME in rats, Life Sci., 91, 159, 10.1016/j.lfs.2012.06.036

McCarthy, 2011, Animal models of preeclampsia; uses and limitations, Placenta, 32, 413, 10.1016/j.placenta.2011.03.010

Liu, 2019, The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia, Hypertens. Res., 42, 928, 10.1038/s41440-018-0193-3

Przybyl, 2016, CD74-Downregulation of placental macrophage-trophoblastic interactions in preeclampsia, Circ. Res., 119, 55, 10.1161/CIRCRESAHA.116.308304

Jauniaux, 1999, In-vivo measurement of intrauterine gases and acid-base values early in human pregnancy, Hum. Reprod., 14, 2901, 10.1093/humrep/14.11.2901

Nye, 2018, Human placental oxygenation in late gestation: experimental and theoretical approaches, J. Physiol., 596, 5523, 10.1113/JP275633